CM H-26 - Hazardous Drug And Hazardous Waste Lists
CM H-26 - Hazardous Drug and Hazardous Waste ListsAntineoplastic Hazardous ntineoplasticMonoclonal AntibodyAfatinibPOAntineoplasticAltretamine AnastrazolePOAntineoplasticArsenic AntineoplasticAntineoplasticBacillus Calmette-Guerin (BCG)IntravesicalAnti-Cancer asticBosutinibBrentuximab vedotinPOIVAntineoplasticAntineoplasticBusulfanIV / ticCarmustine cCrizotinibPOIV / PO / ytarabine (inj)DabrafenibDacarbazine1AntineoplasticConsensus RiskCategoryHazardous WasteHazardous wasteHazardous wasteReviewed/Revised 6/1/2018
Antineoplastic Hazardous abineIVDegarelixSQDocetaxelIVAntineoplasticGnRH eoplasticDoxorubicin LiposomalDoxorubicin / eoplasticEstramustineAntineoplasticEtoposide phosphatePOIV/Inj given orally ineoplasticGemtuzumab ozogamicinIVAntineoplasticGoserelinSQGNRH analogHistrelinGRH AgonistIdarubicinInjectionPO / de/Mesna IrinotecanIVAntineoplasticIrinotecan eConsensus RiskCategoryHazardous ineoplastic2Reviewed/Revised 6/1/2018
Antineoplastic Hazardous DrugsDrugLetrozole / Ribociclib CombinationPOClassAntineoplasticLeuprolide acetateIMGRH ntineoplasticMegestrol cinPO/SuspensionIV / POPO / OralsuspensionIV/ IM /SQ /Topical/ aclitaxelIVAntineoplasticPaclitaxel protein nibPOTamoxifenTemsirolimusPOPO / OralsuspensionInjectionAntineoplasticEstrogen eTemozolomideRouteConsensus RiskCategoryHazardous ardous WasteHazardous viewed/Revised 6/1/2018
Antineoplastic Hazardous tepaIV/intravesicalAntineoplasticTopotecan ogen il (Combo product)TriptorelinPOIM/SQAntineoplasticGnRH nibPOAntineoplasticVemurafenibVinblastine sulfatePOIVAntineoplasticAntineoplasticVincristine sulfateIVAntineoplasticVincristine/Doxorubicin (Combination)IVAntineoplasticVincristine LiposomalIVAntineoplasticVinorelbine plasticConsensus RiskCategoryHazardousWasteNon-Antineoplastic Hazardous DrugsDrugRouteClassAbacavirPO/Oral troviral comboAbacavir/LamivudinePOAntiretroviral MAntiretroviral porinImmunosuppressantCyclosporineIVPO/ IV/ Oral liquid /OpthalmicDeferipronePO/Oral liquidChelating agentAzathioprine4Consensus ticImmunosuppressantReviewed/Revised 6/1/2018
Non-Antineoplastic Hazardous DrugsDrugRouteClassDesogestrel/ethinyl ceptiveTissue protectantNon-steroid estrogenDivalproexPOAnticonvulsantEntecavirPO/ Oral solutionAntiretroviralEstradiol (tablet)POHormoneEstradiol / ns, eEstrogens (conjugated, esterified,combined w/ progestin)Estrogens (estrone, estropipatecombined w/ HormoneEstropipatePOHormoneEthinyl estradiolPOHormoneEthinyl estradiol/drospirenonePOContraceptiveEthinyl estradiol/ethynodiolPOContraceptiveEthinyl estradiol/etonogestrelEthinyl estradiol/ferrousfumarate/norethindrone acet.POContraceptivePOContraceptiveEthinyl estradiol/levonorgestrelPOContraceptiveEthinyl estradiol/norelgestrominPOContraceptiveEthinyl estradiol/norethindronePOContraceptiveEthinyl estradiol/norethindrone acetatePOContraceptiveEthinyl estradiol/norgestimatePOContraceptiveEthinyl logic Gefitinib (tablet)POTK orLiraglutideSQLiraglutide & Insulin degludecSQMedroxyprogesterone acetatePO/IVIncretin eMethimazolePOAntithyroidConsensus RiskCategoryAntiviral5Hazardous wasteReviewed/Revised 6/1/2018
Non-Antineoplastic Hazardous DrugsDrugRouteClassCholesterol loweringagentMipomersenInjectionMycophenolate enolic acid ECPOImmunosuppressantNevirapinePO/Oral O/ Injection, longactingSERMAlpha 1 blockerPhenytoinPOIV/PO /Chewable /SuspensionProgesteronePO/IM/Topical (gel)HormoneProgestinsPO/IM/Topical M-tab/Oralliquid /IM(microspheres)SirolimusPO / Oral suspensionImmunosuppressantSpironolactonePO / Oral SuspensionDiureticSpironolactone / HydrochlorthiazidePOIV/PO/ Topical /Oral mideAnticonvulsantCell cPOImmunosuppressantPyrimadine ticValganciclovirPO / Oral suspensionAntiviralValproic acidIV/PO/Oral liquidAnticonvulsantZidovudineIV/PO / Oral solutionAntiretroviralPO6Consensus RiskCategoryReviewed/Revised 6/1/2018
Reproductive (Non-antineoplastic) Risk Hazardous inoin noidEndothelan RecAntagonistEndothelan RecAntagonistDopamine receptoragonistCetrorelix acetateSQGRH retinoinTopicalOvulation stimulatorAnti-acnecombinationClomipheneOvulation i-goutDehydroepiandrosterone (DHEA)Depo-TestosteronePOHormonal AID/prostaglandinDinoprostone Alpha reductaseinhibitorGanirelix acetateSQGRH AntagonistGonadotropin, chorionicInjectionIcatibantIVOvulation stimulatorBradykinin recantagonistIsotretinoinPOLomitapidePORetinoid for acneCholesterol SQOvulation OProstaglandinNafarelinIntranasalGRH AgonistNorethindronePOContraceptiveNorethindrone acetatePOContraceptive7Consensus RiskCategoryHazardous wasteBenzodiazipineAnti-fungalReviewed/Revised 6/1/2018
Reproductive (Non-antineoplastic) Risk Hazardous nPeginesatideInjectionPentetate calcium trisodiumIV/inhSomatostatin analogErythrocytestimulatorAntidote / ChelatingagentPhentermine/TopiramateOralWeight loss drugPlerixaforSQHematopoetic agentRibavirin (tablet)POAntiviralRibavirin (N95 inhalation)Ribavirin/interferon ep C virusPulmonary odiazipineTestosterone /OralsuspensionTretinoin (capsule, cream, gel)Oral, TopicalRetinoidUlipristalOralIV/ PO prasidoneIM/POAntipyschoticZoledronic roic acidVigabatrinZonisamide8Consensus RiskCategoryAnticonvulsantHazardous wasteAnticonvulsantAnti-fungalHazardous wasteAnticonvulsantReviewed/Revised 6/1/2018
Hazardous WasteDrugConsensus Risk CategoryAlbuterol /Ipratropium MDI CanistersHazardous Waste OnlyAlbuterol MDI CanistersAlcohol, dehydrated 98%Hazardous Waste OnlyHazardous Waste OnlyReproductive (Nonantineoplastic) RiskHazardous WasteAlitretinoin topical productsAmyl NitrateHazardous Waste OnlyArgatrobanHazardous Waste OnlyArsenic trioxideAntineoplasticHazardous Waste, 2 methods, note well:- Empty vials or IV bags – place in black bin- Vials/IV bags w/ 3% remaining – return topharmacy (DT or CC) for EHS pick upBeclomethasone MDI CanistersHazardous Waste OnlyBudesonide/Fomoterol MDI CanistersHazardous Waste OnlyChloral hydrateHazardous Waste OnlyChlorambucilAntineoplasticHazardous WasteChromium Solution (Undiluted)DaunorubicinHazardous Waste OnlyAntineoplasticHazardous WasteAntineoplasticHazardous WasteFluticasone MDI CanistersHazardous Waste OnlyFluticasone/Salmeterol MDI CanistersHazardous Waste OnlyInsulin aspart (all strengths/combinations)Hazardous Waste OnlyInsulin glargine (all strengths/combinations)Hazardous Waste OnlyInsulin lispro (all strengths/combinations)Hazardous Waste OnlyIpratropium MDI CanistersHazardous Waste OnlyIsosorbide Dinitrate TabsHazardous Waste OnlyLevalbuterol MDI cannistersHazardous Waste OnlyLindaneLiraglutide & Insulin degludecHazardous Waste OnlyLispro InsulinHazardous Waste OnlyLopinavir-rotonavir SolutionHazardous Waste OnlyMastisol adhesiveHazardous Waste OnlyMelphalan (inj)AntineoplasticHazardous WasteCyclophosphamideNon-AntineoplasticHazardous Waste9Reviewed/Revised 6/1/2018
Hazardous WasteDrugConsensus Risk CategoryMitomycin (inj)AntineoplasticHazardous WasteNicotine inhalers, patches, gum and wrappersHazardous Waste OnlyNitroglycerin tabs, patches, inject, dripsHazardous Waste OnlyOlodaterol MDI canistersHazardous Waste OnlyOxybutyninHazardous Waste OnlyPhenol LiquidHazardous Waste OnlyReserpine TabletsHazardous Waste OnlySelenium Injection Solution (Undiluted)Hazardous Waste OnlySelenium Sulfide LotionSilver Nitrate SticksHazardous Waste OnlyHazardous Waste Only – 2 methods, note well:Unused Silver Nitrate Sticks-Return topharmacy (DT or CC) for EHS pick upUsed Silver Nitrate Sticks – place in regulartrashSilver sulfadiazine topical productsHazardous Waste OnlyStreptozocinAntineoplasticHazardous WasteThimerosol (Vaccines containing)Hazardous Waste OnlyTiotropium MDI Canisters (respi-mat)Hazardous Waste OnlyTiotropium/Olodaterol MDI CanistersHazardous Waste OnlyTrace Elements (Undiluted)Hazardous Waste OnlyTretinoin topical productsReproductive (Nonantineoplastic) RiskHazardous WasteTrichloroacetic acidHazardous Waste OnlyTrifluridine/TipiracilAntineoplasticHazardous WasteWarfarinReproductive (Nonantineoplastic) RiskHazardous Waste10Reviewed/Revised 6/1/2018
Selenium Injection Solution (Undiluted) Hazardous Waste Only Selenium Sulfide Lotion Hazardous Waste Only Silver Nitrate Sticks Hazardous Waste Only – 2 methods, note well : Unused Silver Nitrate Sticks -Return to pharmacy (DT or CC) for EHS pick up Used Silver Nitrate Sticks – place in regular .
the hazardous Materials table in 49 CFr 172.101. note: dot hazardous materials include all resource Conservation and recovery act (rCra) hazardous waste and Comprehensive environmental response, Compensation, and liability act (CerCla) hazardous substances. Hazardous Waste as regulated by epa in 40 CFr 261 In general, a waste is hazardous .
Conduct detailed inspection of hazardous areas installations dust atmospheres Conduct detailed inspection of hazardous areas installations pressurisation Manage compliance of hazardous areas Report on the integrity of explosion-protected equipment in a hazardous area UEENEEM078A UEENEEM080A UEE42611 Certificate IV Hazardous Areas - Electrical
Laboratory Hazardous Waste Disposal Procedures 8 Disposal of Biohazardous Waste 9 Disposal of Sharps (and Syringes) 12 . For a list of chemicals that are considered non-hazardous visit the Non-Hazardous Chemical Disposal Guide. Regularly Scheduled Hazardous Waste Pick-up . ESF picks up hazardous waste throughout UBC on a scheduled basis. Pick .
member requests a refill of the drug, at which time the member will receive a 60-day supply of the drug. If the Food and Drug Administration deems a drug on our formulary to be unsafe or the drug’s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary and provide notice to members who take the drug.
If the Food and Drug Administration deems a drug on our formulary to be unsafe or the drug’s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary and provide notice to members who take the drug. Other changes. We may make other changes that affect members currently taking a drug. For
(drug-drug interaction), food, beverages, dietary supplements the person is consuming (drug-nutrient/food interaction) or another disease the person has (drug-disease interaction). A drug interaction is a situation in which a substance affects the activity of a drug, i.e.
the construction of drugs, drug users, drug producers and drug traffickers as ‘the antagonistic drug Other’ (Herschinger, 2011) or existential threat. Initially the ‘Other’ was seen to be drug users, however gradually drug trafficking organisations (DTOs) and then ‘narco-terrorists’ became seen as the most dangerous drug ‘Other .
English Language Arts Model Curriculum with Instructional Supports . Code . Standard . Reading Standards for Literature Key Ideas and details . RL.2.1 . Ask and answer such questions as who, what, where, when, why, and how to demonstrate understanding of key details in a text. RL.2.2 : Analyze literary text development. a. Determine the lesson or moral. b. Retell stories, including fables and .
